Toggle navigation
Home
Search
Services
Blog
Contact
About
402 - RFP: N43-CM-87007-68 Topic 251: Development of Anticancer Agents Reques
Quintessence Biosciences, Inc., Madison, WI, United States
Search grants from Quintessence Biosciences, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Development of Next Generation Galeterone Analogs for Prostate Cancer Therapy
Promoting Physical Activity in Young Adult Cancer Survivors Using mHealth and Adaptive Tailored Feedback Strategies
To Understand/Augment OX40-mediated Tumor Immunotherapy
Stem Cell Self-Renewal mammary Carcinogenesis
Functional Spliceosomes and Extrinisic Splicing Factors
Recently added grants:
The role of corticostriatal circuits in visually-guided behavior
Measurement of Individualized Factors Associated with Tinnitus Burden
Folding and chaperone interactions of multi-domain proteins
RNA Toxicity and Muscle Regeneration
Epigenetic regulation by tumor suppressor p53
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
261200800028C-0-0-1
Application #
7694109
Study Section
Project Start
2008-09-30
Project End
2009-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2008
Total Cost
$170,367
Indirect Cost
Institution
Name
Quintessence Biosciences, Inc.
Department
Type
DUNS #
003575649
City
Madison
State
WI
Country
United States
Zip Code
53719
Comments
Be the first to comment on this grant